---
$id: https://graph.org.ai/products/commodity/51151654
$type: Product
source: UNSPSC
code: "51151654"
title: "Obidoxime"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Obidoxime

**UNSPSC Code**: 51151654
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticholinergic agent with the molecular formula C14H16N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N6KNE1QA9O, chemically known as 4,4-bis-(hydroxyiminomethyl)-1,1-oxydimethylen-dipyridinium-kation but generally known as obidoxime, which bears US NIH Compound Identifier 5485192. European Medicines Agency schedules Obidoxime in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14676MIG. World Health Organization schedules obidoxime in its Anatomical Therapeutic Chemical (ATC) Classification. OBIDOXIME is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, OBIDOXIME remains the US FDA Preferred Term for this commodity. Obidoxime bears US NLM identifiers UMLS ID C0086728 and NCI Concept Code C84023. SMILES: O(CN1CC/C(=C/[NH]=O)CC1)CN1CC/C(=C/[NH]=O)CC1. .

